Intratumor heterogeneity alters most effective drugs in designed combinations
The substantial spatial and temporal heterogeneity observed in patient tumors poses considerable challenges for the design of effective drug combinations with predictable outcomes. Currently, the implications of tissue heterogeneity and sampling bias during diagnosis are unclear for selection and su...
Main Authors: | Zhao, Boyang, Hemann, Michael, Lauffenburger, Douglas A |
---|---|
Other Authors: | Massachusetts Institute of Technology. Computational and Systems Biology Program |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2015
|
Online Access: | http://hdl.handle.net/1721.1/93760 https://orcid.org/0000-0003-4610-1707 |
Similar Items
-
Rational drug combinations design against intratumoral heterogeneity and clonal evolution
by: Zhao, Boyang
Published: (2016) -
Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations
by: Sun, Daphne S., et al.
Published: (2017) -
Modeling Tumor Clonal Evolution for Drug Combinations Design
by: Zhao, Boyang, et al.
Published: (2018) -
Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
by: Zhao, Boyang, et al.
Published: (2014) -
The impact of intratumor heterogeneity on anti-tumor immunity
by: Nguyen, Kim Bich
Published: (2023)